Clinical Social Workers in Hull, MA Accepting Medicare
5 Clinical Social Workers found. Showing 1 - 5
 Rebecca Macdonald, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 81 Central Avenue, Hull, MA 02043 Phone: 781-925-2040 |
 Andre John, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 485 Nantasket Ave Unit C, Hull, MA 02045 Phone: 781-925-3500 Fax: 781-925-3505 |
Laura Haffty Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 485 Nantasket Ave, Unit C, Hull, MA 02045 Phone: 860-830-6357 |
Lori Ann Bertram Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9 Park Ave Apt 306, Hull, MA 02045 Phone: 781-738-8198 |
Deana Kelly Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 Massasoit Ave # 1, Hull, MA 02045 Phone: 781-366-8986 |
News Archive
Outdoor adventure program may be effective in reducing severity of ASD symptoms, study finds
A new Tel Aviv University study finds outdoor challenge-based interventions may be effective in reducing the overall severity of Autism Spectrum Disorder (ASD) symptoms.
Online advertising potentially effective in delivering targeted cancer prevention education
Online advertising based on Google search terms is a potentially effective way to deliver targeted cancer prevention education, according to a study led by Eleni Linos, MD, DrPH, an assistant professor of dermatology at UC San Francisco.
New study says nurses could carry some of the GP work load
According to new research Australia's "crisis in manpower" currently being experienced regarding general practice doctors could be alleviated if better use was made of the expertise of practice nurses.
CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders
CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.
› Verified 5 days ago
Counselors
Clinical Social Workers
Dentists
Occupational Therapists
Pharmacists